Platelet Rich Plasma in Erectile Dysfunction A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
DOI:
https://doi.org/10.37506/ijfmt.v17i1.18906Keywords:
Platelet rich plasma, erectile dysfunction, p-shot, intracavernosal injectionAbstract
Background: The studies postulate that platelet-rich plasma (PRP) injections improve key elements of
neovascualrity to erectile dysfunction (ED).
Aim: Double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of PRP injections in
patients with mild and moderate ED. Exclusion criteria were patient undergo sever ED
Methods: Study is accomplished in Alnuman teaching hospital 2019 and 2022 over 59 patients were complaining
mild to moderate ED, four sessions of P-shot 2 weeks apart each session.
Results: In period 3, 6 months’ interval, a response was achieved by 35/42 (83%) patients in the PRP group
compared to 5/17 (29%) in the placebo group.
Key words: Platelet rich plasma, erectile dysfunction, p-shot, intracavernosal injection.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
https://creativecommons.org/licenses/by-nc/2.0/deed.en